Inogen Financials

INGN Stock  USD 6.64  0.04  0.61%   
Based on the analysis of Inogen's profitability, liquidity, and operating efficiency, Inogen Inc is not in a good financial situation at this time. It has a very high probability of going through financial hardship in July. At this time, Inogen's Total Current Assets are very stable compared to the past year. As of the 22nd of June 2025, Short Term Debt is likely to grow to about 5 M, while Total Assets are likely to drop about 294.4 M. Key indicators impacting Inogen's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Debt Equity Ratio0.220.1116
Way Up
Slightly volatile
Current Ratio3.542.4183
Way Up
Slightly volatile
The financial analysis of Inogen is a critical element in measuring its lifeblood. Investors should not minimize Inogen's ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.

Net Income

(34.09 Million)

  
Build AI portfolio with Inogen Stock
Understanding current and past Inogen Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Inogen's financial statements are interrelated, with each one affecting the others. For example, an increase in Inogen's assets may result in an increase in income on the income statement.

Inogen Inc Earnings Geography

Inogen Stock Summary

Inogen competes with Neuropace, SurModics, Pulmonx Corp, Apyx Medical, and CVRx. Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California. Inogen operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 1021 people.
Specialization
Health Care, Health Care Equipment & Services
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
ISINUS45780L1044
CUSIP45780L104
LocationCalifornia; U.S.A
Business Address859 Ward Drive,
SectorHealth Care Equipment & Supplies
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.inogen.com
Phone805 562 0500
CurrencyUSD - US Dollar

Inogen Key Financial Ratios

Inogen Key Balance Sheet Accounts

202020212022202320242025 (projected)
Total Assets461.9M489.5M405.0M326.2M296.2M294.4M
Other Current Liab34.0M35.8M30.7M60.9M39.9M25.1M
Net Debt(202.0M)(208.9M)(163.7M)(103.6M)(94.4M)(99.1M)
Retained Earnings75.6M69.3M(14.5M)(116.9M)(152.8M)(145.2M)
Accounts Payable12.5M10.3M18.2M27K16.6M13.3M
Cash212.0M235.5M187.0M125.5M113.8M130.4M
Net Receivables31.8M25.8M64.4M42.2M30.1M31.5M
Inventory24.8M31.9M34.1M21.8M24.8M20.4M
Other Current Assets17.9M26.0M19.2M14.5M16.7M10.2M
Total Liab112.2M119.3M107.6M121.4M122.3M74.0M
Total Current Assets305.7M329.2M304.6M207.1M185.5M204.8M
Short Term Debt1.9M6.8M7.0M3.7M2.8M5.0M
Intangible Assets68.8M60.1M177K34.6M30.5M22.2M
Other Liab47.8M47.4M34.5M22.5M25.9M20.4M
Other Assets19.3M17.1M3.4M2.4M2.2M2.1M
Net Tangible Assets234.1M247.7M277.1M264.4M304.0M242.1M
Good Will33.2M33.0M32.9M10.1M9.5M15.6M
Capital Surpluse263.3M273.5M299.5M312.1M358.9M273.5M

Inogen Key Income Statement Accounts

202020212022202320242025 (projected)
Interest Expense18.3M25.3M21.0M2.8M3.3M6.4M
Total Revenue308.5M358.0M377.2M315.7M335.7M258.8M
Gross Profit138.2M176.5M153.5M126.7M154.7M120.1M
Operating Income(12.0M)(12.4M)19.1M(109.4M)(42.5M)(40.4M)
Ebit(12.0M)9.2M(48.5M)(76.5M)(42.5M)(40.4M)
Research Development14.1M16.6M21.9M20.8M21.6M22.7M
Ebitda6.6M30.9M(25.0M)(58.3M)(21.5M)(20.4M)
Cost Of Revenue170.3M181.5M223.7M189.0M181.0M138.7M
Income Before Tax(5.3M)8.7M(83.3M)(102.3M)(36.5M)(34.7M)
Net Income(5.8M)(6.3M)(83.8M)(102.4M)(35.9M)(34.1M)
Income Tax Expense549K15.0M504K105K(588K)(558.6K)
Tax Provision549K15.0M504K779K(588K)(558.6K)
Interest Income909K129K2.8M6.7M5.2M2.7M
Net Interest Income909K129K2.8M6.7M5.2M3.0M

Inogen Key Cash Accounts

202020212022202320242025 (projected)
Change To Inventory7.6M(10.8M)(5.6M)7.9M(3.5M)(3.7M)
Change In Cash13.9M23.6M(48.5M)(61.5M)(8.1M)(7.7M)
Free Cash Flow19.4M(434K)(58.8M)(30.2M)(11.2M)(10.6M)
Depreciation18.6M21.6M23.5M18.2M21.0M15.5M
Other Non Cash Items16.2M3.0M55.2M59.6M18.9M22.6M
Capital Expenditures17.6M24.1M21.2M27.0M17.1M16.7M
Net Income(5.8M)(6.3M)(83.8M)(102.4M)(35.9M)(34.1M)
End Period Cash Flow212.0M235.5M187.0M125.5M117.4M130.7M
Change To Netincome15.9M12.9M15.8M51.3M59.0M62.0M
Investments(8.2M)9.3M(10.9M)(70.4M)(14.0M)(14.7M)
Change Receivables(16.7M)(8.2M)(6.1M)(51.3M)(46.2M)(43.9M)

Inogen Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Inogen's current stock value. Our valuation model uses many indicators to compare Inogen value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Inogen competition to find correlations between indicators driving Inogen's intrinsic value. More Info.
Inogen Inc is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Inogen's Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Inogen's earnings, one of the primary drivers of an investment's value.

Inogen's Earnings Breakdown by Geography

Inogen Inc Systematic Risk

Inogen's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Inogen volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on Inogen Inc correlated with the market. If Beta is less than 0 Inogen generally moves in the opposite direction as compared to the market. If Inogen Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Inogen Inc is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Inogen is generally in the same direction as the market. If Beta > 1 Inogen moves generally in the same direction as, but more than the movement of the benchmark.

Inogen Thematic Clasifications

Inogen Inc is part of several thematic ideas from Trump Equities to Obamacare Repeal. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Get More Thematic Ideas
Today, most investors in Inogen Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Inogen's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Inogen growth as a starting point in their analysis.

Price Earnings To Growth Ratio

0.0967

At this time, Inogen's Price Earnings To Growth Ratio is very stable compared to the past year.

Inogen June 22, 2025 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Inogen help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Inogen Inc. We use our internally-developed statistical techniques to arrive at the intrinsic value of Inogen Inc based on widely used predictive technical indicators. In general, we focus on analyzing Inogen Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Inogen's daily price indicators and compare them against related drivers.
When determining whether Inogen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Inogen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Inogen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Inogen Inc Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inogen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inogen. If investors know Inogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.873
Earnings Share
(1.15)
Revenue Per Share
14.109
Quarterly Revenue Growth
0.055
Return On Assets
(0.06)
The market value of Inogen Inc is measured differently than its book value, which is the value of Inogen that is recorded on the company's balance sheet. Investors also form their own opinion of Inogen's value that differs from its market value or its book value, called intrinsic value, which is Inogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inogen's market value can be influenced by many factors that don't directly affect Inogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Inogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.